FDA Fingerprints On MDUFMA Trigger? MDMA Holds Hill To Funding Targets
This article was originally published in The Gray Sheet
Executive Summary
A revision of the "trigger" within the Medical Device User Fee & Modernization Act to account for appropriations shortfalls would represent a breach of the original agreement by Congress, FDA and industry, the Medical Device Manufacturers Association contends